 | • レポートコード：MRC2202A035 • 出版社/出版日：Transparency Market Research / 2021年11月 • レポート形態：英文、PDF、126ページ • 納品方法：Eメール • 産業分類：医療 |
| Single User | ￥857,660 (USD5,795) | ▷ お問い合わせ |
| Multi User | ￥1,301,660 (USD8,795) | ▷ お問い合わせ |
| Corporate License | ￥1,745,660 (USD11,795) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| Transparency Market Research社の本調査レポートは、世界の孤立性線維性腫瘍（SFT）治療市場を調査対象とし、序論、仮定・調査手法、エグゼクティブサマリー、市場概要、市場見通し、治療別（手術、放射線療法、補助化学療法）分析、エンドユーザー別分析、地域別（北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ）分析など、以下の構成でまとめています。 ・序論 ・仮定・調査手法 ・エグゼクティブサマリー ・市場概要 ・市場見通し ・世界の孤立性線維性腫瘍（SFT）治療市場規模：治療別（手術、放射線療法、補助化学療法） ・世界の孤立性線維性腫瘍（SFT）治療市場規模：エンドユーザー別 ・世界の孤立性線維性腫瘍（SFT）治療市場規模：地域別（北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ） |
Solitary Fibrous Tumor Treatment Market – Scope of Report
TMR’s report on the global solitary fibrous tumor treatment market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2021 to 2031. The report provides the revenue of the global solitary fibrous tumor treatment market for the period 2017–2031, considering 2020 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global solitary fibrous tumor treatment market from 2021 to 2031.
The report has been prepared after extensive research. Primary research involved bulk of research efforts, wherein analysts carried out interviews with key industry leaders and opinion makers. Secondary research involved referring to key players’ literature, annual reports, press releases, and relevant documents to understand the global solitary fibrous tumor treatment market.
Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global solitary fibrous tumor treatment market.
The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments and sub-segments included in the scope of the study. Moreover, the report sheds light on changing competitive dynamics in the global solitary fibrous tumor treatment market. These serve as valuable tools for existing market players as well as entities interested in participating in the global solitary fibrous tumor treatment market.
The report also delves into the competitive landscape of the global solitary fibrous tumor treatment market. Key players operating in the global solitary fibrous tumor treatment market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global solitary fibrous tumor treatment market that have been profiled in this report.
Key Questions Answered in Solitary Fibrous Tumor Treatment Market Report
What is the sales/revenue generated by treatment providers across all regions during the forecast period?
What are the opportunities in the global solitary fibrous tumor treatment market?
What are the major drivers, restraints, opportunities, and threats in the global market?
Which region is set to expand at the fastest CAGR during the forecast period?
Which application segment is expected to generate the highest revenue globally in 2031?
What are the market positions of different companies operating in the global market?
Solitary Fibrous Tumor Treatment Market – Research Objectives and Research Approach
The comprehensive report on the global solitary fibrous tumor treatment market begins with an overview, followed by the scope and objectives of the study. Following this, the report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of treatments.
For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that have been appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of market shares of key segments in the past and at the end of the forecast period.
The report analyzes the global solitary fibrous tumor treatment market in terms of treatment, end-user, and region. Key segments under each criteria have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders to make informed business decisions for investment in the global solitary fibrous tumor treatment market.
レポート目次1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Solitary Fibrous Tumor Treatment Market
4. Market Overview
4.1. Introduction & Overview
4.2. Market Dynamics
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunities
4.3. Global Solitary Fibrous Tumor Treatment Market Analysis and Forecast, 2017–2031
5. Market Outlook
5.1. Pipeline Analysis
5.2. COVID-19 Impact Analysis
5.3. Patients Population Data, 2018-2020
6. Global Solitary Fibrous Tumor Treatment Market Analysis and Forecast, by Treatment
6.1. Introduction & Definition
6.2. Global Solitary Fibrous Tumor Treatment Market Value (US$ Mn) Forecast, by Treatment, 2017–2031
6.2.1. Surgery
6.2.2. Radiation Therapy
6.2.3. Adjuvant Chemotherapy
6.3. Global Solitary Fibrous Tumor Treatment Market Attractiveness Analysis, by Treatment
7. Global Solitary Fibrous Tumor Treatment Market Analysis and Forecast, by End-user
7.1. Introduction & Definition
7.2. Global Solitary Fibrous Tumor Treatment Market Value (US$ Mn) Forecast, by End-user, 2017–2031
7.2.1. Ambulatory Surgical Centers
7.2.2. Hospitals
7.2.3. Others
7.3. Global Solitary Fibrous Tumor Treatment Market Attractiveness Analysis, by End-user
8. Global Solitary Fibrous Tumor Treatment Market Analysis and Forecast, by Region
8.1. Key Findings
8.2. Global Solitary Fibrous Tumor Market Value (US$ Mn) Forecast, by Region
8.2.1. North America
8.2.2. Europe
8.2.3. Asia Pacific
8.2.4. Latin America
8.2.5. Middle East & Africa
8.3. Global Solitary Fibrous Tumor Treatment Market Attractiveness Analysis, by Region
9. North America Solitary Fibrous Tumor Treatment Market Analysis and Forecast
9.1. Introduction
9.2. North America Solitary Fibrous Tumor Treatment Market Value (US$ Mn) Forecast, by Treatment, 2017–2031
9.2.1. Surgery
9.2.2. Radiation Therapy
9.2.3. Adjuvant Chemotherapy
9.3. North America Solitary Fibrous Tumor Treatment Market Value (US$ Mn) Forecast, by End-user, 2017–2031
9.3.1. Ambulatory Surgical Centers
9.3.2. Hospitals
9.3.3. Others
9.4. North America Solitary Fibrous Tumor Treatment Market Value (US$ Mn) Forecast, by Country, 2017–2031
9.4.1. U.S.
9.4.2. Canada
9.5. North America Solitary Fibrous Tumor Market Attractiveness Analysis
9.5.1. By Treatment
9.5.2. By End-user
9.5.3. By Country
10. Europe Solitary Fibrous Tumor Treatment Market Analysis and Forecast
10.1. Introduction
10.2. Europe Solitary Fibrous Tumor Treatment Market Value (US$ Mn) Forecast, by Treatment, 2017–2031
10.2.1. Surgery
10.2.2. Radiation Therapy
10.2.3. Adjuvant Chemotherapy
10.3. Europe Solitary Fibrous Tumor Market Value (US$ Mn) Forecast, by End-user, 2017–2031
10.3.1. Ambulatory Surgical Centers
10.3.2. Hospitals
10.3.3. Others
10.4. Europe Solitary Fibrous Tumor Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
10.4.1. Germany
10.4.2. U.K.
10.4.3. France
10.4.4. Spain
10.4.5. Italy
10.4.6. Rest of Europe
10.5. Europe Solitary Fibrous Tumor Treatment Market Attractiveness Analysis
10.5.1. By Treatment
10.5.2. By End-user
10.5.3. By Country/Sub-region
11. Asia Pacific Solitary Fibrous Tumor Treatment Market Analysis and Forecast
11.1. Introduction
11.2. Asia Pacific Solitary Fibrous Tumor Market Value (US$ Mn) Forecast, by Treatment, 2017–2031
11.2.1. Surgery
11.2.2. Radiation Therapy
11.2.3. Adjuvant Chemotherapy
11.3. Asia Pacific Solitary Fibrous Tumor Treatment Market Value (US$ Mn) Forecast, by End-user, 2017–2031
11.3.1. Ambulatory Surgical Centers
11.3.2. Hospitals
11.3.3. Others
11.4. Asia Pacific Solitary Fibrous Tumor Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
11.4.1. China
11.4.2. Japan
11.4.3. India
11.4.4. Australia & New Zealand
11.4.5. Rest of Asia Pacific
11.5. Asia Pacific Solitary Fibrous Tumor Market Attractiveness Analysis
11.5.1. By Treatment
11.5.2. By End-user
11.5.3. By Country/Sub-region
12. Latin America Solitary Fibrous Tumor Treatment Market Analysis and Forecast
12.1. Introduction
12.2. Latin America Solitary Fibrous Tumor Treatment Market Value (US$ Mn) Forecast, by Treatment, 2017–2031
12.2.1. Surgery
12.2.2. Radiation Therapy
12.2.3. Adjuvant Chemotherapy
12.3. Latin America Solitary Fibrous Tumor Treatment Market Value (US$ Mn) Forecast, by End-user, 2017–2031
12.3.1. Ambulatory Surgical Centers
12.3.2. Hospitals
12.3.3. Others
12.4. Latin America Solitary Fibrous Tumor Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
12.4.1. Brazil
12.4.2. Mexico
12.4.3. Rest of Latin America
12.5. Latin America Solitary Fibrous Tumor Market Attractiveness Analysis
12.5.1. By Treatment
12.5.2. By End-user
12.5.3. By Country/Sub-region
13. Middle East & Africa Solitary Fibrous Tumor Treatment Market Analysis and Forecast
13.1. Introduction
13.2. Middle East & Africa Solitary Fibrous Tumor Market Value (US$ Mn) Forecast, by Treatment, 2017–2031
13.2.1. Surgery
13.2.2. Radiation Therapy
13.2.3. Adjuvant Chemotherapy
13.3. Middle East & Africa Solitary Fibrous Tumor Market Value (US$ Mn) Forecast, by End-user, 2017–2031
13.3.1. Ambulatory Surgical Centers
13.3.2. Hospitals
13.3.3. Others
13.4. Middle East & Africa Solitary Fibrous Tumor Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
13.4.1. GCC Countries
13.4.2. South Africa
13.4.3. Rest of Middle East & Africa
13.5. Middle East & Africa Solitary Fibrous Tumor Market Attractiveness Analysis
13.5.1. By Treatment
13.5.2. By End-user
13.5.3. By Country/Sub-region
13.5.4. Competition Landscape
13.6. Competition Landscape
13.7. Company Profiles
13.7.1. Pfizer, Inc.
13.7.1.1. Company Overview (HQ, Business Segments, Employee Strength)
13.7.1.2. Growth Strategies
13.7.1.3. SWOT Analysis
13.7.2. F. Hoffmann-La Roche Ltd.
13.7.2.1. Company Overview (HQ, Business Segments, Employee Strength)
13.7.2.2. Growth Strategies
13.7.2.3. SWOT Analysis
13.7.3. Eli Lilly and Company
13.7.3.1. Company Overview (HQ, Business Segments)
13.7.3.2. Growth Strategies
13.7.3.3. SWOT Analysis
13.7.4. Bayer AG
13.7.4.1. Company Overview (HQ, Business Segments, Employee Strength)
13.7.4.2. Growth Strategies
13.7.4.3. SWOT Analysis
13.7.5. Novartis AG
13.7.5.1. Company Overview (HQ, Business Segments)
13.7.5.2. Growth Strategies
13.7.5.3. SWOT Analysis
Table 01: Global Solitary Fibrous Tumor Treatment Market Value (US$ Mn) Forecast, by Treatment, 2017–2031
Table 02: Global Solitary Fibrous Tumor Treatment Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 03: Global Solitary Fibrous Tumor Treatment Market Value (US$ Mn) Forecast, by Region, 2017–2031
Table 04: North America Solitary Fibrous Tumor (SFT) Treatment Market Value (US$ Mn) Forecast, by Country, 2017–2031
Table 05: North America Solitary Fibrous Tumor (SFT) Treatment Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 06: North America Solitary Fibrous Tumor (SFT) Treatment Market Value (US$ Mn) Forecast, by Treatment, 2017–2031
Table 07: Europe Solitary Fibrous Tumor (SFT) Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 08: Europe Solitary Fibrous Tumor (SFT) Treatment Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 09: Europe Solitary Fibrous Tumor (SFT) Treatment Market Value (US$ Mn) Forecast, by Treatment, 2017–2031
Table 10: Asia Pacific Solitary Fibrous Tumor (SFT) Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 11: Asia Pacific Solitary Fibrous Tumor (SFT) Treatment Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 12: Asia Pacific Solitary Fibrous Tumor (SFT) Treatment Market Value (US$ Mn) Forecast, by Treatment, 2017–2031
Table 13: Latin America Solitary Fibrous Tumor (SFT) Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 14: Latin America Solitary Fibrous Tumor (SFT) Treatment Market Value (US$ Mn) Forecast, by Treatment, 2017–2031
Table 15: Latin America Solitary Fibrous Tumor (SFT) Treatment Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 16: Middle East & Africa Solitary Fibrous Tumor (SFT) Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 17: Middle East & Africa Solitary Fibrous Tumor (SFT) Treatment Market Value (US$ Mn) Forecast, by Treatment, 2017–2031
Table 18: Middle East & Africa Solitary Fibrous Tumor (SFT) Treatment Market Value (US$ Mn) Forecast, by End-user, 2017–2031